It has been observed that GLUT1 deficiency sensitizes cancer cells to phenformin-induced cell death, whereas GLUT1 restoration in NBR2-deficient cells rescues the increased cell death after phenformin treatment. The gene discussed is SLC2A1; the disease is cancer.